Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Published Online July 10, 2008
Science DOI: 10.1126/science.1157610

Reports

Submitted on March 11, 2008
Accepted on June 20, 2008

Regulation of CD45 Alternative Splicing by Heterogeneous Ribonucleoprotein, HnRNPLL

Shalini Oberdoerffer 1, Luis Ferreira Moita 2{dagger}, Daniel Neems 1, Rui P. Freitas 2{dagger}, Nir Hacohen 3, Anjana Rao 1*

1 Department of Pathology, Immune Disease Institute, Harvard Medical School, Boston, MA, 02115, USA.
2 Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Charlestown, MA, 02129, USA.
3 Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Charlestown, MA, 02129, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA.

* To whom correspondence should be addressed.
Anjana Rao , E-mail: arao{at}ibi.harvard.edu

{dagger}Present address: Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.

The transition from naïve to activated T cells is marked by alternative splicing of pre–messenger RNA encoding the transmembrane phosphatase CD45. Using a short hairpin RNA screen, we identified heterogeneous ribonucleoprotein L-like (hnRNPLL) as a critical inducible regulator of CD45 alternative splicing. HnRNPLL was up-regulated in stimulated T cells, bound CD45 transcripts, and was both necessary and sufficient for CD45 alternative splicing. Depletion or overexpression of hnRNPLL in B and T cell lines and primary T cells resulted in reciprocal alteration of CD45RA and RO expression. Exon array analysis suggested that hnRNPLL acts as a global regulator of alternative splicing in activated T cells. Induction of hnRNPLL during haematopoietic cell activation and differentiation may allow cells to rapidly shift their transcriptomes to favor proliferation and inhibit cell death.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Nucleosomes are well positioned in exons and carry characteristic histone modifications.
R. Andersson, S. Enroth, A. Rada-Iglesias, C. Wadelius, and J. Komorowski (2009)
Genome Res. 19, 1732-1741
   Abstract »    Full Text »    PDF »
Auto- and Cross-Regulation of the hnRNP L Proteins by Alternative Splicing.
O. Rossbach, L.-H. Hung, S. Schreiner, I. Grishina, M. Heiner, J. Hui, and A. Bindereif (2009)
Mol. Cell. Biol. 29, 1442-1451
   Abstract »    Full Text »    PDF »
The Heterogeneous Nuclear Ribonucleoprotein L Is an Essential Component in the Ca2+/Calmodulin-dependent Protein Kinase IV-regulated Alternative Splicing through Cytidine-Adenosine Repeats.
J. Yu, Y. Hai, G. Liu, T. Fang, S. K. P. Kung, and J. Xie (2009)
J. Biol. Chem. 284, 1505-1513
   Abstract »    Full Text »    PDF »
A cell-based screen for splicing regulators identifies hnRNP LL as a distinct signal-induced repressor of CD45 variable exon 4.
J. D. Topp, J. Jackson, A. A. Melton, and K. W. Lynch (2008)
RNA 14, 2038-2049
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)